Mitochondria as target for antiischemic drugs.

[1]  P. Cozzone,et al.  Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia. , 2000, Cardiovascular research.

[2]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[3]  S. Moussaoui,et al.  The anti-oxidant ebselen antagonizes the release of the apoptogenic factor cytochrome c induced by Fe2+/citrate in rat liver mitochondria , 2000, Neuroscience Letters.

[4]  M. Spedding,et al.  Antagonists and the purinergic nerve hypothesis: 2, 2'-pyridylisatogen tosylate (PIT), an allosteric modulator of P2Y receptors. A retrospective on a quarter century of progress. , 2000, Journal of the autonomic nervous system.

[5]  M. Beal.  Energetics in the pathogenesis of neurodegenerative diseases , 2000, Trends in Neurosciences.

[6]  F. Ushikubi,et al.  Ranolazine Attenuates Palmitoyl‐l‐carnitine‐induced Mechanical and Metabolic Derangement in the Isolated, Perfused Rat Heart , 2000, The Journal of pharmacy and pharmacology.

[7]  B. Testa,et al.  [3H]‐Trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance , 2000, British journal of pharmacology.

[8]  C. Michiels,et al.  Protection by bilobalide of the ischaemia‐induced alterations of the mitochondrial respiratory activity , 2000, Fundamental & clinical pharmacology.

[9]  B. Siesjö,et al.  Characteristics of the Calcium‐Triggered Mitochondrial Permeability Transition in Nonsynaptic Brain Mitochondria , 2000, Journal of neurochemistry.

[10]  G. Grover,et al.  ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. , 2000, Journal of molecular and cellular cardiology.

[11]  G. Lopaschuk,et al.  The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. , 2000, Circulation research.

[12]  K. Tanonaka,et al.  Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart , 2000, British journal of pharmacology.

[13]  P. Oliveira,et al.  Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria. , 2000, Archives of biochemistry and biophysics.

[14]  G. Lopaschuk.  Regulation of carbohydrate metabolism in ischemia and reperfusion. , 2000, American heart journal.

[15]  R. Mallet.  Pyruvate: metabolic protector of cardiac performance. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  D. Ricquier,et al.  The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. , 2000, The Biochemical journal.

[17]  G. Angelini,et al.  Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. , 2000, Cardiovascular research.

[18]  J. Sastre,et al.  Mitochondria, oxidative stress and aging , 2000, Free radical research.

[19]  D. Emerich.  Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? , 2000, Trends in Neurosciences.

[20]  Y. Sagara,et al.  Propofol Hemisuccinate Protects Neuronal Cells from Oxidative Injury , 1999, Journal of neurochemistry.

[21]  A. Imperato,et al.  Effects of Ebselen, a Glutathione Peroxidase Mimic, in Several Models of Mitochondrial Dysfunction , 1999, Annals of the New York Academy of Sciences.

[22]  T. Ohta,et al.  Effects of ebselen on cerebral ischemia and reperfusion evaluated by microdialysis. , 1999, Neurological research.

[23]  Luca Scorrano,et al.  Mitochondria and cell death. Mechanistic aspects and methodological issues. , 1999, European journal of biochemistry.

[24]  S. Moncada,et al.  BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Tillement,et al.  Médicaments interagissant avec les mitochondries: effets anti-ischémiques de la trimétazidine. , 1999 .

[26]  C. Sluse-Goffart,et al.  EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation. , 1999, Free radical biology & medicine.

[27]  M. Crompton,et al.  The mitochondrial permeability transition pore. , 1999, Biochemical Society symposium.

[28]  A. Terzic,et al.  ATP‐sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria , 1999, The Journal of physiology.

[29]  John J. Lemasters,et al.  Mitochondrial Dysfunction in the Pathogenesis of Necrotic and Apoptotic Cell Death , 1999, Journal of bioenergetics and biomembranes.

[30]  E. Fontaine,et al.  Progress on the Mitochondrial Permeability Transition Pore: Regulation by Complex I and Ubiquinone Analogs , 1999, Journal of bioenergetics and biomembranes.

[31]  M Crompton,et al.  The mitochondrial permeability transition pore and its role in cell death. , 1999, The Biochemical journal.

[32]  D. Das,et al.  The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. , 1999, Free radical biology & medicine.

[33]  S. Kuroda,et al.  Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the Rat , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  J. Remacle,et al.  Protection of mitochondrial respiration activity by bilobalide. , 1999, Biochemical pharmacology.

[35]  L. Szweda,et al.  Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Wieloch,et al.  Differences in the Activation of the Mitochondrial Permeability Transition Among Brain Regions in the Rat Correlate with Selective Vulnerability , 1999, Journal of neurochemistry.

[37]  G. Kroemer,et al.  Arsenic trioxide, a novel mitochondriotoxic anticancer agent? , 1999, Journal of the National Cancer Institute.

[38]  J. Lemasters,et al.  Contribution of increased mitochondrial free Ca2+ to the mitochondrial permeability transition induced by tert‐butylhydroperoxide in rat hepatocytes , 1999, Hepatology.

[39]  R. Bentley,et al.  Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. , 1999, Transplantation.

[40]  A. Szewczyk,et al.  Mitochondria: a new target for K channel openers? , 1999, Trends in pharmacological sciences.

[41]  G Fiskum,et al.  Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  M. Akahane,et al.  Antianginal Effects of Ranolazine in Various Experimental Models of Angina , 1999, Arzneimittelforschung.

[43]  C. Tetik,et al.  Cytoprotective effect of trimetazidine on 60 minutes of intestinal ischemia-reperfusion injury in rats , 1999, Transplant international : official journal of the European Society for Organ Transplantation.

[44]  M. Beal,et al.  Mitochondria in Neurodegeneration: Bioenergetic Function in Cell Life and Death , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  A. Halestrap,et al.  Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. , 1999, American journal of physiology. Heart and circulatory physiology.

[46]  M. Rudin,et al.  Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. , 1999, The Journal of pharmacology and experimental therapeutics.

[47]  D. Cassarino,et al.  An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration , 1999, Brain Research Reviews.

[48]  M. Peter,et al.  Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid* , 1998, The Journal of Biological Chemistry.

[49]  J. Tillement,et al.  Trimetazidine: Experimental and Clinical Update Review , 1998 .

[50]  A. Halestrap,et al.  Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. , 1998, The Biochemical journal.

[51]  F. Franconi,et al.  Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism. , 1998, Free radical research.

[52]  A. Terzic,et al.  Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. , 1998, American journal of physiology. Heart and circulatory physiology.

[53]  D. Menon,et al.  Propofol Preserves the Viability of Isolated Rat Hepatocyte Suspensions Under an Oxidant Stress , 1998, Anesthesia and analgesia.

[54]  F. S. de la Cuesta,et al.  The In Vitro Effects of Propofol on Tissular Oxidative Stress in the Rat , 1998, Anesthesia and analgesia.

[55]  F. Ichas,et al.  A Ubiquinone-binding Site Regulates the Mitochondrial Permeability Transition Pore* , 1998, The Journal of Biological Chemistry.

[56]  C. Palmeira,et al.  Ischemic heart disease: the role of mitochondria--carvedilol prevents lipid peroxidation of mitochondrial membranes. , 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[57]  P. Cozzone,et al.  Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury. , 1998, The American journal of cardiology.

[58]  Ian J. Reynolds,et al.  Glutamate-induced neuron death requires mitochondrial calcium uptake , 1998, Nature Neuroscience.

[59]  S. Budd,et al.  Mitochondria and neuronal glutamate excitotoxicity. , 1998, Biochimica et biophysica acta.

[60]  F. Di Lisa,et al.  The role of mitochondria in the salvage and the injury of the ischemic myocardium. , 1998, Biochimica et biophysica acta.

[61]  S. Javadov,et al.  Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. , 1998, Biochimica et biophysica acta.

[62]  John Calvin Reed,et al.  Bcl-2 family proteins and mitochondria. , 1998, Biochimica et biophysica acta.

[63]  J. P. De La Cruz,et al.  Effect of propofol on oxidative stress in an in vitro model of anoxia-reoxygenation in the rat brain , 1998, Brain Research.

[64]  O. Saydam,et al.  Cytoprotective Effect of Trimetazidine on 75 min Warm Renal Ischemia-Reperfusion Injury in Rats , 1998, European Surgical Research.

[65]  T. Wieloch,et al.  Cyclosporin A, But Not FK 506, Protects Mitochondria and Neurons against Hypoglycemic Damage and Implicates the Mitochondrial Permeability Transition in Cell Death , 1998, The Journal of Neuroscience.

[66]  J. Tillement,et al.  Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial function. , 1998, The Journal of pharmacology and experimental therapeutics.

[67]  Carlos Portera-Cailliau,et al.  Neurodegeneration in Excitotoxicity, Global Cerebral Ischemia, and Target Deprivation: A Perspective on the Contributions of Apoptosis and Necrosis , 1998, Brain Research Bulletin.

[68]  T. Yue,et al.  Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. , 1998, European journal of pharmacology.

[69]  Yongge Liu,et al.  Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? , 1998, Circulation.

[70]  Anibal E. Vercesi,et al.  The Thiol-specific Antioxidant Enzyme Prevents Mitochondrial Permeability Transition , 1998, The Journal of Biological Chemistry.

[71]  F. G. Diaz,et al.  Real-time measurement of ischemia-evoked glutamate release in the cerebral cortex of four and eleven vessel rat occlusion models , 1998, Brain Research.

[72]  J. Tillement,et al.  Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition. , 1998, European journal of pharmacology.

[73]  J. Mccormack,et al.  Ranolazine: a novel metabolic modulator for the treatment of angina. , 1998, General pharmacology.

[74]  P. Carrupt,et al.  Evidence for the existence of [3H]‐trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore , 1998, British journal of pharmacology.

[75]  N. Maulik,et al.  Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. , 1998, Free radical biology & medicine.

[76]  H. Schelbert,et al.  Regulation of pyruvate dehydrogenase activity and glucose metabolism in post-ischaemic myocardium. , 1998, Biochimica et biophysica acta.

[77]  V. Skulachev.  Uncoupling: new approaches to an old problem of bioenergetics. , 1998, Biochimica et biophysica acta.

[78]  Y. Abiko,et al.  Propofol Improves Functional and Metabolic Recovery in Ischemic Reperfused Isolated Rat Hearts , 1998, Anesthesia and analgesia.

[79]  M. Spedding,et al.  2-2'-Pyridylisatogen, a selective allosteric modulator of P2 receptors, is a spin trapping agent. , 1998, Biochemical and biophysical research communications.

[80]  B. Herman,et al.  Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. , 1997, American journal of physiology. Cell physiology.

[81]  M. Smith,et al.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.

[82]  C. Ikonomidou,et al.  Topical Review: Glutamate in Neurologic Diseases , 1997, Journal of child neurology.

[83]  D. Graham,et al.  Neuroprotective efficacy of ebselen, an anti‐oxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion , 1997, British journal of pharmacology.

[84]  R. Bersin,et al.  Dichloroacetate as metabolic therapy for myocardial ischemia and failure. , 1997, American heart journal.

[85]  L. Barrier,et al.  Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. , 1997, Life sciences.

[86]  J. Tillement,et al.  Trimetazidine prevents renal injury in the isolated perfused pig kidney exposed to prolonged cold ischemia. , 1997, Transplantation.

[87]  V. Skulachev,et al.  High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria , 1997, FEBS letters.

[88]  J. Tillement,et al.  Comparison of the effects of cyclosporine A and trimetazidine on Ca2+‐dependent mitochondrial swelling , 1997, Fundamental & clinical pharmacology.

[89]  A. Halestrap,et al.  Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury , 1997 .

[90]  A. Nègre-Salvayre,et al.  A role for uncoupling protein‐2 as a regulator of mitochondrial hydrogen peroxide generation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  B. Kristal,et al.  Mitochondrial Permeability Transition in the Central Nervous System: Induction by Calcium Cycling‐Dependent and ‐Independent Pathways , 1997, Journal of neurochemistry.

[92]  Cryer Hg.  Therapeutic approaches for clinical ischemia and reperfusion injury. , 1997 .

[93]  Shu-sen Liu,et al.  Generating, Partitioning, Targeting and Functioning of Superoxide in Mitochondria , 1997, Bioscience reports.

[94]  L. Scorrano,et al.  On the Voltage Dependence of the Mitochondrial Permeability Transition Pore , 1997, The Journal of Biological Chemistry.

[95]  A. Demiryurek,et al.  Propofol Is a Peroxynitrite Scavenger , 1997, Anesthesia and analgesia.

[96]  B. Matta,et al.  Propofol neuroprotection in a rat model of ischaemia reperfusion injury. , 1997, European journal of anaesthesiology.

[97]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[98]  M. Ozaki,et al.  Ebselen, a novel anti-oxidant compound, protects the rat liver from ischemia-reperfusion injury , 1997, Transplant international : official journal of the European Society for Organ Transplantation.

[99]  W. Trommer,et al.  Cyclosporine A-induced oxidative stress in rat hepatocytes. , 1997, The Journal of pharmacology and experimental therapeutics.

[100]  J. Mccormack,et al.  Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions , 1997 .

[101]  V. Papadopoulos,et al.  In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. , 1996, Endocrinology.

[102]  J. Lemasters,et al.  Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition. , 1996, Neuroscience.

[103]  M. Weiner,et al.  Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts. , 1996, The American journal of physiology.

[104]  R. Berge,et al.  Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury. , 1996, European journal of pharmacology.

[105]  S. Orrenius,et al.  Calcineurin and mitochondrial function in glutamate‐induced neuronal cell death , 1996, FEBS letters.

[106]  T. Yanagihara,et al.  Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. , 1996, Life sciences.

[107]  M. Rigoulet,et al.  Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. , 1996, European journal of biochemistry.

[108]  D. Choi,et al.  Ischemia-induced neuronal apoptosis , 1996, Current Opinion in Neurobiology.

[109]  J. Horowitz,et al.  Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. , 1996, Biochemical pharmacology.

[110]  B. Siesjö,et al.  Calcium-related damage in ischemia. , 1996, Life sciences.

[111]  C. Dioudis,et al.  Lipid peroxidation after acute renal ischemia and reperfusion in rats: the effect of trimetazidine. , 1996, Renal failure.

[112]  V. Yarov-Yarovoy,et al.  The Mitochondrial K Channel as a Receptor for Potassium Channel Openers (*) , 1996, The Journal of Biological Chemistry.

[113]  P. Carrupt,et al.  Trimetazidine reverses calcium accumulation and impairment of phosphorylation induced by cyclosporine A in isolated rat liver mitochondria. , 1996, The Journal of pharmacology and experimental therapeutics.

[114]  M. Lamy,et al.  Effect of propofol on in vitro lipid peroxidation induced by different free radical generating systems: a comparison with vitamin E. , 1996, Journal of neurosurgical anesthesiology.

[115]  J. Port,et al.  Cardiac adrenergic receptor effects of carvedilol. , 1996, European heart journal.

[116]  A. Szewczyk,et al.  ATP-regulated K+ channel in mitochondria: Pharmacology and function , 1996, Journal of bioenergetics and biomembranes.

[117]  B. Chernyak,et al.  Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites (*) , 1996, The Journal of Biological Chemistry.

[118]  K. M. Wyatt,et al.  Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism. , 1996, Journal of molecular and cellular cardiology.

[119]  J. Crestanello,et al.  Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment. , 1996, The Journal of thoracic and cardiovascular surgery.

[120]  A. Cossarizza,et al.  Control of apoptosis by the cellular ATP level , 1996, FEBS letters.

[121]  D. Pfeiffer,et al.  Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. , 1995, Biochemistry.

[122]  G. Brown,et al.  Control and kinetic analysis of ischemia-damaged heart mitochondria: which parts of the oxidative phosphorylation system are affected by ischemia? , 1995, Biochimica et biophysica acta.

[123]  O. Lindvall,et al.  Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. , 1995, Acta physiologica Scandinavica.

[124]  A. El-Fattah,et al.  Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: effect of ginkgo biloba extract. , 1995, Pharmacological research.

[125]  T. Schewe.  Molecular actions of ebselen--an antiinflammatory antioxidant. , 1995, General pharmacology.

[126]  R. Vetter,et al.  Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir. , 1995, The American journal of physiology.

[127]  A. Biegon,et al.  Development of HU-211 as a neuroprotectant for ischemic brain damage. , 1995, Neurological research.

[128]  M. Zoratti,et al.  The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.

[129]  J. Mazat,et al.  Effects of the anaesthetic propofol on the calcium‐induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential , 1995, FEBS letters.

[130]  A. Vercesi,et al.  Ca(2+)-induced mitochondrial membrane permeabilization: role of coenzyme Q redox state. , 1995, The American journal of physiology.

[131]  P. M. Matthews,et al.  Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders , 1995, Neurology.

[132]  G. Dallner,et al.  Biochemical, physiological and medical aspects of ubiquinone function. , 1995, Biochimica et biophysica acta.

[133]  B. Siesjö,et al.  N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[134]  B. Herman,et al.  Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. , 1995, The Biochemical journal.

[135]  A. Halestrap,et al.  Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. , 1995, The Biochemical journal.

[136]  C. Malloy,et al.  Direct Evidence That Perhexiline Modifies Myocardial Substrate Utilization from Fatty Acids to Lactate , 1995, Journal of cardiovascular pharmacology.

[137]  D. Graham,et al.  The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat , 1995, Neuroscience Letters.

[138]  P. Bernardi,et al.  Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane , 1994, Journal of bioenergetics and biomembranes.

[139]  M. Zoratti,et al.  Electrophysiology of the inner mitochondrial membrane , 1994, Journal of bioenergetics and biomembranes.

[140]  L. Demaison,et al.  Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. , 1994, Journal of molecular and cellular cardiology.

[141]  P. Benefield,et al.  Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders. , 1994, Drugs & aging.

[142]  J. Dykens.  Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration , 1994, Journal of neurochemistry.

[143]  P. M. Sokolove,et al.  The mitochondrial permeability transition. Interactions of spermine, ADP, and inorganic phosphate. , 1994, The Journal of biological chemistry.

[144]  B. Herman,et al.  ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition. , 1994, The American journal of physiology.

[145]  E. Lakatta,et al.  Coenzyme Q10 enhances cardiac functional and metabolic recovery and reduces Ca2+ overload during postischemic reperfusion. , 1994, The American journal of physiology.

[146]  R. Bersin,et al.  Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. , 1994, Journal of the American College of Cardiology.

[147]  J. Phillis,et al.  α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia , 1994, Brain Research.

[148]  A. Guillouzo,et al.  Inhibition by perhexiline of oxidative phosphorylation and the β‐oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions , 1994, Hepatology.

[149]  A. Sanbe,et al.  Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment. , 1994, The Journal of pharmacology and experimental therapeutics.

[150]  S. Yoshida,et al.  In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig. , 1994, The Journal of pharmacology and experimental therapeutics.

[151]  T. Williams,et al.  Trimetazidine Inhibits Neutrophil Accumulation After Myocardial Ischaemia and Reperfusion in Rabbits , 1993, Journal of cardiovascular pharmacology.

[152]  M. A. Matlib,et al.  Modulation of intramitochondrial free Ca2+ concentration by antagonists of Na(+)-Ca2+ exchange. , 1993, Trends in pharmacological sciences.

[153]  J. Mccormack,et al.  Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation. , 1993, Journal of molecular and cellular cardiology.

[154]  M. Spedding,et al.  Protective effects of ranolazine in guinea‐pig hearts during low‐flow ischaemia and their association with increases in active pyruvate dehydrogenase , 1993, British journal of pharmacology.

[155]  C. Guarnieri,et al.  Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. , 1993, Pharmacology.

[156]  A. Vercesi.  Ca2+ transport and oxidative damage of mitochondria. , 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[157]  M. Yokota,et al.  Protective Effect of FK506 on Ischemia/Reperfusion‐Induced Myocardial Damage in Canine Heart , 1993, Journal of cardiovascular pharmacology.

[158]  P. Bernardi,et al.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. I. Evidence for two separate Me2+ binding sites with opposing effects on the pore open probability. , 1993, The Journal of biological chemistry.

[159]  M. Verdys,et al.  Improvement of Long‐Term Preservation of Isolated Arrested Rat Heart: Beneficial Effect of the Antiischemic Agent Trimetazidine , 1993, Journal of cardiovascular pharmacology.

[160]  R. Bersin,et al.  A Controlled Clinical Trial of Dichloroacetate for Treatment of Lactic Acidosis in Adults , 1992 .

[161]  Y. Shiga,et al.  Cyclosporin A protects against ischemia-reperfusion injury in the brain , 1992, Brain Research.

[162]  A. Vercesi,et al.  Protective effect of trifluoperazine on the mitochondrial damage induced by Ca2+ plus prooxidants. , 1992, Biochemical pharmacology.

[163]  S. Orrenius,et al.  Cyclosporin A protects hepatocytes against prooxidant-induced cell killing. A study on the role of mitochondrial Ca2+ cycling in cytotoxicity. , 1992, Biochemical pharmacology.

[164]  E. Lakatta,et al.  Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. , 1992, Circulation research.

[165]  J. Farber,et al.  Protection by cyclosporin A of cultured hepatocytes from the toxic consequences of the loss of mitochondrial energization produced by 1-methyl-4-phenylpyridinium. , 1992, Biochemical pharmacology.

[166]  S. Renaud,et al.  Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.

[167]  M. Zoratti,et al.  The mitochondrial megachannel is the permeability transition pore , 1992, Journal of bioenergetics and biomembranes.

[168]  M. Crompton,et al.  Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A. , 1991, Journal of molecular and cellular cardiology.

[169]  R. Jennings,et al.  Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. , 1991, Journal of molecular and cellular cardiology.

[170]  E. Ruuge,et al.  Free radical metabolites in myocardium during ischemia and reperfusion. , 1991, The American journal of physiology.

[171]  T. Higuti,et al.  ATP-sensitive K+ channel in the mitochondrial inner membrane , 1991, Nature.

[172]  A. Halestrap,et al.  Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. , 1991, The Biochemical journal.

[173]  O. Eriksson.  Effects of the general anaesthetic Propofol on the Ca2+‐induced permeabilization of rat liver mitochondria , 1991, FEBS letters.

[174]  D. Pessayre,et al.  Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. , 1990, The Journal of pharmacology and experimental therapeutics.

[175]  F. Lam,et al.  Ranolazine--a new drug with beneficial effects on renal preservation. , 1990, Transplantation.

[176]  G. Lopaschuk,et al.  Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. , 1990, The American journal of physiology.

[177]  H. Sies,et al.  Oxidative damage to mitochondria and protection by ebselen and other antioxidants. , 1990, Biochemical pharmacology.

[178]  J. Phillis,et al.  Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-α-phenylnitrone (PBN) , 1990, Neuroscience Letters.

[179]  A. Halestrap,et al.  Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.

[180]  T. Gunter,et al.  Mechanisms by which mitochondria transport calcium. , 1990, The American journal of physiology.

[181]  Y. Park,et al.  Protection against hypoxic injury in isolated-perfused rat heart by ruthenium red. , 1990, The Journal of pharmacology and experimental therapeutics.

[182]  J. Mccormack,et al.  Role of calcium ions in regulation of mammalian intramitochondrial metabolism. , 1990, Physiological reviews.

[183]  P. Stacpoole.  The pharmacology of dichloroacetate. , 1989, Metabolism: clinical and experimental.

[184]  M. Dempsey,et al.  Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. , 1989, The Journal of biological chemistry.

[185]  P. Olley,et al.  Etomoxir, a Carnitine Palmitoyltransferase I Inhibitor, Protects Hearts From Fatty Acid‐Induced Ischemic Injury Independent of Changes in Long Chain Acylcarnitine , 1988, Circulation research.

[186]  C. Labrid,et al.  Trimetazidine, a cellular anti-ischemic agent , 1988 .

[187]  M. Chiesi,et al.  Structural dependency of the inhibitory action of benzodiazepines and related compounds on the mitochondrial Na+-Ca2+ exchanger. , 1988, Biochemical pharmacology.

[188]  G. Gores,et al.  Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes. , 1988, The American journal of physiology.

[189]  A. Crevât,et al.  Action of cyclosporine on mitochondrial calcium fluxes , 1987, Journal of bioenergetics and biomembranes.

[190]  I. Nasser,et al.  Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. , 1987, The Biochemical journal.

[191]  R. Ferrari,et al.  Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. , 1985, Journal of Molecular and Cellular Cardiology.

[192]  A. Vacheron,et al.  Surgical management of late prosthetic valve endocarditis. , 1983, European heart journal.

[193]  R. Burges,et al.  Protection of the ischaemic dog heart by oxfenicine. , 1981, Life sciences.

[194]  M. G. Page,et al.  Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart. , 1980, Life sciences.

[195]  D. Jewitt,et al.  Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris. , 1980, European heart journal.

[196]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. , 1979, Archives of biochemistry and biophysics.

[197]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. , 1979, Archives of biochemistry and biophysics.

[198]  M. Spedding,et al.  ANTAGONISM OF THE INHIBITORY EFFECTS OF ADENOSINE 5′‐TRIPHOSPHATE ON THE ISOLATED TAENIA OF THE GUINEA‐PIG CAECUM: STRUCTURE‐ACTIVITY RELATIONSHIPS WITHIN A SERIES OF ISATOGEN DERIVATIVES , 1978, British journal of pharmacology.

[199]  P. J. Randle,et al.  Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. , 1974, The Biochemical journal.

[200]  J. Tillement,et al.  Pharmacological limitation of damage to renal medulla after cold storage and transplantation by trimetazidine. , 2000, The Journal of pharmacology and experimental therapeutics.

[201]  J. Tillement,et al.  Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. , 2000, Journal of the American Society of Nephrology : JASN.

[202]  P. Langsjoen,et al.  Overview of the use of CoQ10 in cardiovascular disease , 1999, BioFactors.

[203]  J. Tillement,et al.  Effects of resveratrol on the rat brain respiratory chain. , 1999, Drugs under experimental and clinical research.

[204]  K. Takakura,et al.  Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.

[205]  G. Kroemer,et al.  The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.

[206]  S. Mortensen,et al.  Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. , 1997, Molecular aspects of medicine.

[207]  D. Noble,et al.  Modeling of internal pH, ion concentration, and bioenergetic changes during myocardial ischemia. , 1997, Advances in experimental medicine and biology.

[208]  Z. Drahota,et al.  The role of mitochondria in aging. , 1996, Physiological research.

[209]  R. Ferrari.  The role of mitochondria in ischemic heart disease. , 1996, Journal of cardiovascular pharmacology.

[210]  J. Shen,et al.  Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury. , 1995, Biochemistry and molecular biology international.

[211]  P. Corr,et al.  Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. , 1994, Circulation research.

[212]  K. Stolze,et al.  Ischemia/reperfusion impairs mitochondrial energy conservation and triggers O2.- release as a byproduct of respiration. , 1993, Free radical research communications.

[213]  J. Bonventre,et al.  Kidney preservation ex vivo for transplantation. , 1992, Annual review of medicine.

[214]  J. Parratt.  Myocardial Response to Acute Injury , 1992 .

[215]  D. Acosta,et al.  Mitochondrial regulation of superoxide by Ca2+: an alternate mechanism for the cardiotoxicity of doxorubicin. , 1991, Toxicology and applied pharmacology.

[216]  Y. Naito,et al.  Protection by seleno-organic compound, Ebselen, against acute gastric mucosal injury induced by ischemia-reperfusion in rats. , 1990, Advances in experimental medicine and biology.

[217]  J. Krieglstein,et al.  Pharmacology of cerebral ischemia : proceedings of the International Symposium on Pharmacology of Cerebral Ischemia, held in Marburg (FRG) on 16-17 July 1986 , 1986 .

[218]  J. Hill,et al.  Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. , 1988, The American journal of cardiology.

[219]  John J. Lemasters,et al.  Integration of Mitochondrial Function , 1988, Springer US.

[220]  K. Garlid.  Mitochondrial Volume Control , 1988 .

[221]  N. Blavet,et al.  [Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils]. , 1986, Presse medicale.

[222]  Y. Nakamura,et al.  Improvement in recovery of left ventricular function during reperfusion with coenzyme Q10 in isolated working rat heart. , 1985, Cardiovascular research.